QLS-111-FDC

N/A

Report date: 2026/03/20 20:03:07
NME

Base Information

Drug NameQLS-111-FDC
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionKATP channels modulators
TargetsKATP channels
Therapy Area/IndicationsGlaucoma, Open-AngleOcular Hypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsYes QLS-111
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesQlaris Bio Inc
China Registration ClassN/A

Develop Information

Active CompaniesQlaris Bio Inc
Inactive CompaniesN/A
Active IndicationsGlaucoma, Open-AngleOcular Hypertension
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A